138 related articles for article (PubMed ID: 33811967)
1. Characteristics of immune induction by transcutaneous vaccination using dissolving microneedle patches in mice.
Hirobe S; Susai R; Takeuchi H; Eguchi R; Ito S; Quan YS; Kamiyama F; Okada N
Int J Pharm; 2021 May; 601():120563. PubMed ID: 33811967
[TBL] [Abstract][Full Text] [Related]
2. Analysis of immune response induction mechanisms implicating the dose-sparing effect of transcutaneous immunization using a self-dissolving microneedle patch.
Ito S; Hirobe S; Yamashita R; Sugiyama A; Takeuchi H; Eguchi R; Yoshida J; Oyamada T; Tachibana M; Okada N
Vaccine; 2022 Feb; 40(6):862-872. PubMed ID: 34998604
[TBL] [Abstract][Full Text] [Related]
3. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens.
Matsuo K; Yokota Y; Zhai Y; Quan YS; Kamiyama F; Mukai Y; Okada N; Nakagawa S
J Control Release; 2012 Jul; 161(1):10-7. PubMed ID: 22306332
[TBL] [Abstract][Full Text] [Related]
4. Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection.
Lopez PA; Denny M; Hartmann AK; Alflen A; Probst HC; von Stebut E; Tenzer S; Schild H; Stassen M; Langguth P; Radsak MP
J Dermatol Sci; 2017 Sep; 87(3):252-259. PubMed ID: 28655469
[TBL] [Abstract][Full Text] [Related]
5. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.
Matsuo K; Okamoto H; Kawai Y; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
J Neuroimmunol; 2014 Jan; 266(1-2):1-11. PubMed ID: 24315156
[TBL] [Abstract][Full Text] [Related]
6. Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch.
Hirobe S; Azukizawa H; Hanafusa T; Matsuo K; Quan YS; Kamiyama F; Katayama I; Okada N; Nakagawa S
Biomaterials; 2015 Jul; 57():50-8. PubMed ID: 25913250
[TBL] [Abstract][Full Text] [Related]
7. Dissolving Microneedle Patches for Dermal Vaccination.
Leone M; Mönkäre J; Bouwstra JA; Kersten G
Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Activity of CpG-Oligonucleotide Administered Transcutaneously in Combination with Vaccination Using a Self-Dissolving Microneedle Patch in Mice.
Hirobe S; Kawakita T; Yamasaki T; Ito S; Tachibana M; Okada N
Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960226
[TBL] [Abstract][Full Text] [Related]
9. Characteristic of K3 (CpG-ODN) as a Transcutaneous Vaccine Formulation Adjuvant.
Ito S; Hirobe S; Kawakita T; Saito M; Quan YS; Kamiyama F; Ishii KJ; Nagao M; Fujisawa T; Tachibana M; Okada N
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32183437
[TBL] [Abstract][Full Text] [Related]
10. Current Progress in Particle-Based Systems for Transdermal Vaccine Delivery.
Pielenhofer J; Sohl J; Windbergs M; Langguth P; Radsak MP
Front Immunol; 2020; 11():266. PubMed ID: 32174915
[TBL] [Abstract][Full Text] [Related]
11. Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device.
Hirobe S; Azukizawa H; Matsuo K; Zhai Y; Quan YS; Kamiyama F; Suzuki H; Katayama I; Okada N; Nakagawa S
Pharm Res; 2013 Oct; 30(10):2664-74. PubMed ID: 23775442
[TBL] [Abstract][Full Text] [Related]
12. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
[TBL] [Abstract][Full Text] [Related]
13. Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza.
Matsuo K; Hirobe S; Yokota Y; Ayabe Y; Seto M; Quan YS; Kamiyama F; Tougan T; Horii T; Mukai Y; Okada N; Nakagawa S
J Control Release; 2012 Jun; 160(3):495-501. PubMed ID: 22516091
[TBL] [Abstract][Full Text] [Related]
14. Transcutaneous immunization in auricle skin induces antigen-specific mucosal and systemic immune responses in BALB/c mice.
Nagano H; Jimura T; Nagano M; Makise T; Miyashita K; Kurono Y
Auris Nasus Larynx; 2017 Aug; 44(4):411-416. PubMed ID: 27637556
[TBL] [Abstract][Full Text] [Related]
15. Induction of anti-chlamydial mucosal immunity by transcutaneous immunization is enhanced by topical application of GM-CSF.
Hickey DK; Bao S; Ikeda LT; Carey AJ; Beagley KW
Curr Mol Med; 2005 Sep; 5(6):599-605. PubMed ID: 16178770
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles.
Hsueh KJ; Chen MC; Cheng LT; Lee JW; Chung WB; Chu CY
Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():78-87. PubMed ID: 28131383
[TBL] [Abstract][Full Text] [Related]
17. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells.
Belyakov IM; Hammond SA; Ahlers JD; Glenn GM; Berzofsky JA
J Clin Invest; 2004 Apr; 113(7):998-1007. PubMed ID: 15057306
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous immunization system using a hydrotropic formulation induces a potent antigen-specific antibody response.
Takatani-Nakase T; Tokuyama E; Komai M; Takahashi K
PLoS One; 2012; 7(10):e47980. PubMed ID: 23110149
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Immune Responses Conferring Cross-Protection by Skin Vaccination With a Tri-Component Influenza Vaccine Using a Microneedle Patch.
Zhu W; Li S; Wang C; Yu G; Prausnitz MR; Wang BZ
Front Immunol; 2018; 9():1705. PubMed ID: 30105019
[TBL] [Abstract][Full Text] [Related]
20. Development of Novel Faster-Dissolving Microneedle Patches for Transcutaneous Vaccine Delivery.
Ono A; Ito S; Sakagami S; Asada H; Saito M; Quan YS; Kamiyama F; Hirobe S; Okada N
Pharmaceutics; 2017 Aug; 9(3):. PubMed ID: 28771172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
